Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

1101 - 1110 of 3920 results found

EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease

MeSH Terms

Alzheimer Disease / drug therapy*

Cholinesterase Inhibitors / therapeutic use*

Drug Therapy, Combination*

Excitatory Amino Acid Antagonists / therapeutic use*

Humans

Memantine / therapeutic use*

Practice Guidelines as Topic*

Guideline Contact
R. Schmidt, Medical University of Graz, Department of Neurology, Division of Neurogeriatrics, Auenbruggerplatz 22, 8036 Graz, Austria (tel.: +43 316 385 13136; fax: +43 316 385 14178; e-mail: [email protected])
Keywords
Alzheimer's disease; EFNS/ENS Guidelines; Grading of Recommendations Assessment, Development and Evaluation; cholinesterase inhibitors; dementia; memantine; meta-analysis; treatment.
Publication Date
25 March 2015
Methods Applied
GRADE; systematic review; meta-analysis
Publication Scope
Evidence-Based Medicine
Management
Management: Treatment
Treatment
Management
Treatment, management
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Willingness to Collaborate
Yes

EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood

MeSH Terms

Ataxia / diagnosis*

Ataxia / genetics

Ataxia / therapy*

Chronic Disease

Consensus*

Databases, Factual / statistics & numerical data

Guidelines as Topic / standards*

Humans

Guideline Contact
B. P. C. van de Warrenburg, Department of Neurology 935, Radboud University Nijmegen Medical Centre, Donders Institute for Brain, Cognition and Behaviour, PO Box 9101, 6500 HB Nijmegen, The Netherlands (tel.: 0031 24 3613396; fax: 0031 24 3541122; e-mail: [email protected]).
Keywords
MRI; ataxia; genetic testing; multiple system atrophy; symptomatic treatment.
Publication Date
13 January 2014
Date of Last Evidence Search
September 2012
Methods Applied
Systematic review; evidence classification
Publication Scope
Diagnosis
Management
Management: Treatment
Treatment
Diagnosis, Treatment
Diagnosis-Management
Management
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
10
Willingness to Collaborate
Yes

EFNS/ENS Guidelines for the treatment of ocular myasthenia

MeSH Terms

Cholinesterase Inhibitors / therapeutic use

Databases, Factual / statistics & numerical data

Guidelines as Topic / standards*

Humans

Immunologic Factors / therapeutic use

Myasthenia Gravis / drug therapy*

Myasthenia Gravis / surgery

Thymectomy / methods

Thymectomy / standards

Guideline Contact
E. Kerty, Department of Neurology, Oslo University Hospital, Rikshospitalet, Postbox 4950 Nydalen, 4 Oslo, Norway (tel.: +47 23071829; fax: +47 23070490; e-mail: [email protected]).
Keywords
myasthenia gravis; ocular myasthenia; treatment.
Publication Date
28 January 2014
Methods Applied
Systematic review
Publication Scope
Management
Management: Treatment
Treatment
Treatment, management
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
5
Willingness to Collaborate
Yes

EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease

MeSH Terms

Autonomic Nervous System Diseases / diagnosis

Autonomic Nervous System Diseases / etiology

Brain / pathology

Cognition Disorders / diagnosis

Cognition Disorders / etiology

Databases, Factual / statistics & numerical data

Diagnostic Imaging

Europe

Genetic Testing

Guidelines as Topic*

Humans

Neurophysiology

Neuropsychological Tests

Olfaction Disorders / diagnosis

Olfaction Disorders / etiology

Parkinson Disease / complications

Parkinson Disease / diagnosis*

Risk Factors

Sleep Wake Disorders / diagnosis

Sleep Wake Disorders / etiology

Guideline Contact
A. Berardelli, Dipartimento di Neurologia e Psichiatria, Sapienza, Università di Roma, Viale dell'Università 30, 00185 Rome, Italy (tel./fax: +390649914700; e-mail: [email protected]).
Publication Date
22 December 2012
Methods Applied
Evidence classification; Experts' recommendations
Publication Scope
Diagnosis
Investigation
Management: Treatment
Treatment
Assessment, diagnosis, investigation
Assessment, management
Diagnosis, Treatment
Diagnosis-Management
Management, assessment, investigation
Treatment, management
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
25
Willingness to Collaborate
Yes

Ei-alkoholiperäinen rasvamaksatauti

MeSH Terms

Non-alcoholic Fatty Liver Disease (C06.552.241.519)

Guideline Contact
Raija Sipilä ([email protected])
English Title Translation
Non-alcoholic fatty liver disease (NAFLD)
Publication Date
8.1.2020
Publication Scope
assessment
treatment
Countries of Application
Finland
Guideline Publication Status
Published
Languages
Finnish
Authors
CC (FI)
Publication Year
2020

Einsatz der intraaortalen Ballongegenpulsation in der Herzchirurgie (IABP). S3-LL (DGTHG)

MeSH Terms

Heart (A07.541)

Guideline Contact
Ina Kopp ([email protected])
English Title Translation
Use of intra-aortic balloon counterpulsation in cardiac surgery (IABP)
Keywords
Ballongegenpulsation, Intraaortal, Ballonpumpe, IABP, Herzinsuffizienz, Gegenpulsation, Herzchirurgie
Date for Review
14/09/2029
Publication Date
24/09/2024
Publication Scope
assessment
management
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AWMF (DE)
Publication Year
2024

Einsatz und Behandlung von humaner Milch in Einrichtungen des Gesundheitswesens. S2k-LL (GNPI)

MeSH Terms

Neonatology (H02.403.670.400); Milk; Human (A12.200.467); Milk; Human (J02.200.700.500); Milk; Human (J02.500.350.525.500)

Guideline Contact
Ina Kopp ([email protected])
English Title Translation
Use and treatment of human milk in healthcare facilities
Keywords
Humane Milch, Muttermilch, Frauenmilch, Frauenmilchbank, Qualitätsmanagement, Hazard Analysis and Critical Control Points (HACCP), Milchspenderinnen, Human milk, breast milk, human milk bank, quality management, Hazard Analysis and Critical Control Points (HACCP), human milk donors
Date for Review
20/03/2029
Publication Date
17/05/2024
Publication Scope
management
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AWMF (DE)
Publication Year
2024

Einsatz von Exoskeletten im beruflichen Kontext zur Primär-, Sekundär-, und Tertiärprävention von arbeitsassoziierten Muskel-Skelett-Erkrankungen oder -Beschwerden. S2k-LL (DGAUM)

MeSH Terms

Skeleton (A02.835)

Guideline Contact
Ina Kopp ([email protected])
English Title Translation
Use of exoskeletons in the occupational context for primary, secondary, and tertiary prevention of work-related musculoskeletal disorders or complaints
Date for Review
31/07/2026
Publication Scope
management
Countries of Application
Germany
Guideline Publication Status
Under Review
Languages
German
Authors
AWMF (DE)
Publication Year
2020

Einsatz von Platelet rich Fibrin (PRF) in der dentalen Implantologie. S3-LL (DGZMK, DGI)

MeSH Terms

Platelet-Rich Plasma (A12.207.152.693.600); Platelet-Rich Plasma (A12.207.270.695.600); Platelet-Rich Plasma (A15.145.693.600); Dental Implantation (E04.545.550.280); Dental Implantation (E04.650.230); Dental Implantation (E06.645.550.280); Dental Implantation (E06.231); Dental Implantation (E06.780.314); Dental Implants (D25.339.312); Dental Implants (E06.780.345.593); Dental Implants (E07.695.185); Dental Implants (J01.637.051.339.312); Dental Implants; Single-Tooth (E07.695.185.185); Dental Implants; Single-Tooth (E06.780.345.593.185)

Guideline Contact
Ina Kopp ([email protected])
English Title Translation
use of Platelet rich Fibrin (PRF) in dental implantology
Keywords
Zahnimplantat, Platelet rich Fibrin, fibrinreiches Plasma, Wachstumsfaktoren, Knochenheilung, dental implant, Platelet rich Fibrin, growth factors, bone regeneration
Date for Review
01/12/2027
Publication Date
01/09/2023
Publication Scope
counselling
management
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AWMF (DE)
Publication Year
2023